Please ensure Javascript is enabled for purposes of website accessibility

Aphria Receiving CA$100M Infusion From Strategic Investor

By Eric Volkman - Jan 24, 2020 at 1:22PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is selling a clutch of common stock and warrants in the deal.

Aphria (APHA) is about to get a new major shareholder. The company announced Friday morning that it has entered into an agreement to accept a 100 million Canadian dollars ($76 million) investment from an institutional investor that it did not identify.

For its money, this investor will receive just over 14 million units of the company. Each of these units consists of one share of Aphria common stock, plus a warrant entitling the holder to half a share of same. When taken as a whole, each complete warrant will grant the holder the right to buy one share of common stock at a price of CA$9.26 ($7.04) apiece for two years from the deal's closing date.

All told, the incoming investor is to pay CA$7.12 ($5.41) per each unit.

Canadian paper currency.

Image source: Getty Images

If all warrants are exercised, Aphria's new partner would hold a bit more than 21 million shares of the company's common stock. At the moment, Aprhia has slightly over 250 million shares outstanding.

The company said in its announcement that it will use the proceeds from the deal "to finance international expansion, working capital and general corporate purposes."

Aphria anticipates that the sale will close "on or about" next Friday, Jan. 31. It is subject to approval from the relevant regulatory bodies.

The company, like more than a few of its cannabis industry brethren, has been struggling of late. Earlier this month Aphria reported its Q2 of 2020 results, which revealed a 4% sequential decline in net revenue and a flip into the red on the bottom line.

In late morning trading Friday, the company's share price is falling more steeply than those of peer marijuana stocks. At $5.46, it's currently down by over 5%.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote
Aphria
APHA

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.